Nicole Kiss1,2 1Nutrition and Speech Pathology Department, Peter MacCallum Cancer Centre, East Melbourne, VIC, Australia; 2Department of Cancer Experiences Research, Peter MacCallum Cancer Centre, East Melbourne, VIC, Australia Abstract: Malnutrition and weight loss are prevalent in patients with lung cancer. The impact of malnutrition on patients with cancer, and specifically in patients with lung cancer, has been demonstrated in a large number of studies. Malnutrition has been shown to negatively affect treatment completion, survival, quality of life, physical function, and health care costs. Emerging evidence is providing some insight into which lung cancer patients are at higher nutritional risk. In lung cancer patients treated with ra...
The objective of this article was to investigate the relationship between nutrition and cancer, as i...
Nutrition plays a fundamental role in both the prevention and the treatment of cancer. The aim of th...
IntroductionTrimodality treatment for stage III non-small cell lung cancer (NSCLC), consisting of ch...
Malnutrition and weight loss are prevalent in patients with lung cancer. The impact of malnutrition ...
The prevalence of malnutrition in lung cancer patients across a variety of treatment modalities and ...
Primary lung cancer is one of the most common malignancies. Nowadays, both its morbidity and mortali...
INTRODUCTION: Nutrition has an important role in prevention and management of cancer. It also prolo...
Abstract: Current understanding of the aetiology of lung cancer suggests that oxidative stress is st...
Background & aims: Thoracic radiotherapy is associated with toxicities that can adversely impact nut...
Lung cancer is the leading cause of death worldwide and in Thailand. The treatment of non-small cell...
【Background】 Weight loss in patients with cancer is caused by cancer cachexia and chemotherapy-induc...
Lung cancer is a devastating disease with a high incidence and low survival rates, so recent studies...
Malnutrition is a common cancer treatment side effect, leading to the decreased treatment tolerance ...
A large body of evidence exists, which demonstrates the importance of nutritional support in cancer....
The development of cachexia is common in people with solid tumours such as pancreatic, lung, gastric...
The objective of this article was to investigate the relationship between nutrition and cancer, as i...
Nutrition plays a fundamental role in both the prevention and the treatment of cancer. The aim of th...
IntroductionTrimodality treatment for stage III non-small cell lung cancer (NSCLC), consisting of ch...
Malnutrition and weight loss are prevalent in patients with lung cancer. The impact of malnutrition ...
The prevalence of malnutrition in lung cancer patients across a variety of treatment modalities and ...
Primary lung cancer is one of the most common malignancies. Nowadays, both its morbidity and mortali...
INTRODUCTION: Nutrition has an important role in prevention and management of cancer. It also prolo...
Abstract: Current understanding of the aetiology of lung cancer suggests that oxidative stress is st...
Background & aims: Thoracic radiotherapy is associated with toxicities that can adversely impact nut...
Lung cancer is the leading cause of death worldwide and in Thailand. The treatment of non-small cell...
【Background】 Weight loss in patients with cancer is caused by cancer cachexia and chemotherapy-induc...
Lung cancer is a devastating disease with a high incidence and low survival rates, so recent studies...
Malnutrition is a common cancer treatment side effect, leading to the decreased treatment tolerance ...
A large body of evidence exists, which demonstrates the importance of nutritional support in cancer....
The development of cachexia is common in people with solid tumours such as pancreatic, lung, gastric...
The objective of this article was to investigate the relationship between nutrition and cancer, as i...
Nutrition plays a fundamental role in both the prevention and the treatment of cancer. The aim of th...
IntroductionTrimodality treatment for stage III non-small cell lung cancer (NSCLC), consisting of ch...